Optimised empiric triple and concomitant therapy forHelicobacter pylorieradication in clinical practice: the OPTRICON study

Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole

(2014) S. Sahara et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pilot study: miscellaneous therapy is highly successful forHelicobacter pylorieradication

(2013) F. Sierra et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: Sequential Therapy Appears Superior to Standard Therapy for Helicobacter pylori Infection in Patients Naive to Treatment

(2013) Nadim S. Jafri   ANNALS OF INTERNAL MEDICINE

Rational Helicobacter pylori Therapy: Evidence-Based Medicine Rather Than Medicine-Based Evidence

(2013) David Y. Graham et al.   Clinical Gastroenterology and Hepatology

Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence

(2013) Vikram Kate et al.   DRUGS

III Conferencia Española de Consenso sobre la infección por Helicobacter pylori

(2013) Javier P. Gisbert et al.   Gastroenterologia y Hepatologia

Actualización de la eficacia de la terapia triple para la infección por Helicobacter pylori y de la resistencia a claritromicina en España (2007-2012)

(2013) Javier Molina-Infante et al.   Gastroenterologia y Hepatologia

Is There a Nonbismuth Quadruple Therapy That Can Reliably Overcome Bacterial Resistance?

(2013) Sotirios D. Georgopoulos et al.   GASTROENTEROLOGY

Optimized Nonbismuth Quadruple Therapies Cure Most Patients With Helicobacter pylori Infection in Populations With High Rates of Antibiotic Resistance

(2013) Javier Molina–Infante et al.   GASTROENTEROLOGY

Randomised clinical trial comparing sequential and concomitant therapies forHelicobacter pylorieradication in routine clinical practice

(2013) Adrian G McNicholl et al.   GUT

Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis

(2013) Joon Sung Kim et al.   Gut and Liver

Clinical Evaluation of a Ten-Day Regimen with Esomeprazole, Metronidazole, Amoxicillin, and Clarithromycin for the Eradication ofHelicobacter pyloriin a High Clarithromycin Resistance Area

(2013) Sotirios D. Georgopoulos et al.   HELICOBACTER

Meta-analysis: Is sequential therapy superior to standard triple therapy forHelicobacter pyloriinfection in Asian adults?

(2013) Hyuk Yoon et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

(2013) L. Gatta et al.   BMJ-British Medical Journal

High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates

(2012) J. Sánchez-Delgado et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Letter: the ethics of using inferior regimens in H. pylori randomised trials

(2012) D. Y. Graham et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: esomeprazole or rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori infection

(2012) A. G. McNicholl et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Meta-analysis: sequential therapy for Helicobacter pylori eradication in children

(2012) A. Horvath et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Standard triple and sequential therapies for Helicobacter pylori eradication: An update

(2012) Angelo Zullo et al.   European Journal of Internal Medicine

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Helicobacter pyloriresistance to antibiotics in Europe and its relationship to antibiotic consumption

(2012) Francis Megraud et al.   GUT

Evaluation of a Four-drug, Three-antibiotic, Nonbismuth-containing “Concomitant” Therapy as First-line Helicobacter pylori Eradication Regimen in Greece

(2012) Sotirios Georgopoulos et al.   HELICOBACTER

Nonbismuth Quadruple (Concomitant) Therapy: Empirical and Tailored Efficacy versus Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori and versus Sequential Therapy for Clarithromycin-Resistant Strains

(2012) Javier Molina-Infante et al.   HELICOBACTER

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

(2012) Jyh-Ming Liou et al.   LANCET

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Is Culture Necessary before First-line Treatment for Helicobacter pylori Infection?

(2011) Javier P. Gisbert   INTERNAL MEDICINE

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

(2011) Peter Malfertheiner et al.   LANCET

Helicobacter pylori treatment in the era of increasing antibiotic resistance

(2010) D. Y. Graham et al.   GUT

Sequential Therapy or Triple Therapy for Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Randomized Controlled Trials in Adults and Children

(2009) Luigi Gatta et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing “Concomitant Therapy” Versus Triple Therapy forHelicobacter pyloriEradication

(2009) Abdallah Said Essa et al.   HELICOBACTER

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Sequential therapy vs. standard triple therapies forHelicobacter pyloriinfection: a meta-analysis

(2008) J. L. Tong et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS